Skip to content

Frontlight ResearchEarly access

Institution

Hôpital Rothschild

Paris, FranceWebsite

2running trials
3,952publications (OpenAlex)

Running trials

Not yet recruiting
SERORL Effect of aspirin and folic acid for sudden sensorineural hearing loss
2024-513710-35-00· Phase 3· Assistance Publique Hopitaux De Paris· Source
Recruiting
Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome
NCT04681417· Phase 2/3· Institut Curie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Childhood cancers1 recruiting
Hearing loss1 recruiting

Registry name variants (1)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Rothschild Hospital
Paris Cedex 12, 75571
2 trials
- 2024-513710-35-00SERORL Effect of aspirin and folic acid for sudden sensorineural hearing loss
- NCT04681417Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome

Conditions

Diseases this institution publishes on or runs trials for.

Glaucoma18 works · 0 trials
Macular degeneration12 works · 0 trials
Optic neuritis7 works · 0 trials
Wilson disease6 works · 0 trials
Giant cell arteritis4 works · 0 trials
Tourette syndrome3 works · 0 trials

Institution data: ROR 009kb8w74 (CC0-1.0)Updated 14 Nov 2026

Report an error